North American partner
Will not happen for a while, or untill phase 3 results are out. Which means next year. I dont think any major Pharma will come in this year to do a deal.
I wish these guys would go onto an American exchange we would have much greater exposure and higher stock price. Once again I think management has dropped the ball here.
Some body please tell me how we are going to get to the $2.20 Versant target by 12 months ????.
BB